These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 37577761)
1. De novo CLPTM1 variants with reduced GABA Liu N; Li J; Gao K; Perszyk RE; Zhang J; Wang J; Wu Y; Jenkins A; Yuan H; Traynelis SF; Jiang Y Epilepsia; 2023 Nov; 64(11):2968-2981. PubMed ID: 37577761 [TBL] [Abstract][Full Text] [Related]
2. De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy. Butler KM; Moody OA; Schuler E; Coryell J; Alexander JJ; Jenkins A; Escayg A Brain; 2018 Aug; 141(8):2392-2405. PubMed ID: 29961870 [TBL] [Abstract][Full Text] [Related]
3. Clptm1, a new target in suppressing epileptic seizure by regulating GABA Zhang XL; Zhou JY; Zhang P; Lin L; Mei R; Zhang FL; Chen YM; Li R Kaohsiung J Med Sci; 2023 Jan; 39(1):61-69. PubMed ID: 36519412 [TBL] [Abstract][Full Text] [Related]
4. Altered Channel Conductance States and Gating of GABA Hernandez CC; Kong W; Hu N; Zhang Y; Shen W; Jackson L; Liu X; Jiang Y; Macdonald RL eNeuro; 2017; 4(1):. PubMed ID: 28197552 [TBL] [Abstract][Full Text] [Related]
6. 4-Phenylbutyrate promoted wild-type γ-aminobutyric acid type A receptor trafficking, reduced endoplasmic reticulum stress, and mitigated seizures in Gabrg2 Shen W; Flamm C; Delahanty AJ; Casteel E; Biven M; DeLeeuw MB; Poliquin S; Nwosu G; Randhave K; Kang JQ Epilepsia; 2024 Jan; 65(1):204-217. PubMed ID: 37746768 [TBL] [Abstract][Full Text] [Related]
7. A de novo missense variant in GABRA4 alters receptor function in an epileptic and neurodevelopmental phenotype. Vogel FD; Krenn M; Westphal DS; Graf E; Wagner M; Leiz S; Koniuszewski F; Augé-Stock M; Kramer G; Scholze P; Ernst M Epilepsia; 2022 Apr; 63(4):e35-e41. PubMed ID: 35152403 [TBL] [Abstract][Full Text] [Related]
8. Influence of GABAA receptor gamma2 splice variants on receptor kinetics and isoflurane modulation. Benkwitz C; Banks MI; Pearce RA Anesthesiology; 2004 Oct; 101(4):924-36. PubMed ID: 15448526 [TBL] [Abstract][Full Text] [Related]
9. Gain-of-function variants in GABRD reveal a novel pathway for neurodevelopmental disorders and epilepsy. Ahring PK; Liao VWY; Gardella E; Johannesen KM; Krey I; Selmer KK; Stadheim BF; Davis H; Peinhardt C; Koko M; Coorg RK; Syrbe S; Bertsche A; Santiago-Sim T; Diemer T; Fenger CD; Platzer K; Eichler EE; Lerche H; Lemke JR; Chebib M; Møller RS Brain; 2022 May; 145(4):1299-1309. PubMed ID: 34633442 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of and therapeutic options for a GABRA1 variant linked to epileptic encephalopathy. Bai YF; Chiu M; Chan ES; Axerio-Cilies P; Lu J; Huh L; Connolly MB; Guella I; Farrer MJ; Xu ZD; Liu L; Demos M; Wang YT Mol Brain; 2019 Nov; 12(1):92. PubMed ID: 31707987 [TBL] [Abstract][Full Text] [Related]
11. Properties of a novel GABAA receptor γ2 subunit mutation associated with seizures. Migita K; Yamada J; Nikaido Y; Shi X; Kaneko S; Hirose S; Ueno S J Pharmacol Sci; 2013; 121(1):84-7. PubMed ID: 23257655 [TBL] [Abstract][Full Text] [Related]
12. Molecular and clinical descriptions of patients with GABA Maillard PY; Baer S; Schaefer É; Desnous B; Villeneuve N; Lépine A; Fabre A; Lacoste C; El Chehadeh S; Piton A; Porter LF; Perriard C; Wardé MA; Spitz MA; Laugel V; Lesca G; Putoux A; Ville D; Mignot C; Héron D; Nabbout R; Barcia G; Rio M; Roubertie A; Meyer P; Paquis-Flucklinger V; Patat O; Lefranc J; Gerard M; ; de Bellescize J; Villard L; De Saint Martin A; Milh M Epilepsia; 2022 Oct; 63(10):2519-2533. PubMed ID: 35718920 [TBL] [Abstract][Full Text] [Related]
13. Clptm1 Limits Forward Trafficking of GABA Ge Y; Kang Y; Cassidy RM; Moon KM; Lewis R; Wong ROL; Foster LJ; Craig AM Neuron; 2018 Feb; 97(3):596-610.e8. PubMed ID: 29395912 [TBL] [Abstract][Full Text] [Related]
14. Functional genomics of epilepsy-associated mutations in the GABA Absalom NL; Ahring PK; Liao VW; Balle T; Jiang T; Anderson LL; Arnold JC; McGregor IS; Bowen MT; Chebib M J Biol Chem; 2019 Apr; 294(15):6157-6171. PubMed ID: 30728247 [TBL] [Abstract][Full Text] [Related]
15. De Novo Missense Variants in SLC32A1 Cause a Developmental and Epileptic Encephalopathy Due to Impaired GABAergic Neurotransmission. Platzer K; Sticht H; Bupp C; Ganapathi M; Pereira EM; Le Guyader G; Bilan F; Henderson LB; Lemke JR; Taschenberger H; Brose N; Abou Jamra R; Wojcik SM Ann Neurol; 2022 Dec; 92(6):958-973. PubMed ID: 36073542 [TBL] [Abstract][Full Text] [Related]
18. Rare variants in the GABA Markus F; Angelini C; Trimouille A; Rudolf G; Lesca G; Goizet C; Lasseaux E; Arveiler B; van Slegtenhorst M; Brooks AS; Abou Jamra R; Korenke GC; Neidhardt J; Owczarek-Lipska M Mol Genet Genomic Med; 2020 Sep; 8(9):e1388. PubMed ID: 32588540 [TBL] [Abstract][Full Text] [Related]
19. A novel de novo variant of GABRA1 causes increased sensitivity for GABA in vitro. Steudle F; Rehman S; Bampali K; Simeone X; Rona Z; Hauser E; Schmidt WM; Scholze P; Ernst M Sci Rep; 2020 Feb; 10(1):2379. PubMed ID: 32047208 [TBL] [Abstract][Full Text] [Related]
20. Altered kinetics and benzodiazepine sensitivity of a GABAA receptor subunit mutation [gamma 2(R43Q)] found in human epilepsy. Bowser DN; Wagner DA; Czajkowski C; Cromer BA; Parker MW; Wallace RH; Harkin LA; Mulley JC; Marini C; Berkovic SF; Williams DA; Jones MV; Petrou S Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15170-5. PubMed ID: 12415111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]